While the biotech sector has been generally strong this year, Regeneron has struggled. The stock's return year-to-date is now just 2.53 percent, ...
News
- Strong Earnings and Big Oil Deal Push Stock Prices Higher
- Initial public offerings scheduled to debut next week
Business: Phase 2 biotech developing T-cell Immunotherapies for ... Business: Early stage biotech developing tyrosine kinase inhibitors for treating ...
- Hedge Fund and Insider Trading News: AQR Capital Management, Greenlight Capital, Soros Fund ...
Specialty Insurer Argo Fires Back at Activist Hedge Fund (San Antonio ... the insurer – which has its U.S. headquarters in San Antonio – has generated. ... drugmaker's $74 billion takeover of biotech Celgene Corp on Friday despite a ...
- Nirenberg uses 2019 State of the City speech to push free community college
SAN ANTONIO (KTSA News) — San Antonio mayor Ron Nirenberg used the ... in the area like cyber security, IT, bioscience and advanced manufacturing. ... Specifically, he noted how UTSA and Texas A&M San Antonio are each ...
- UTSA moves closer to coveted research funding status
... funding to four researchers at the University of Texas at San Antonio, moving UTSA closer to National Research University Fund, or NRUF, eligibility ...